Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Michael Campbell, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentSurgery
    Address2340 Sutter Street
    San Francisco CA 94115
    Phone415-885-3710
    vCardDownload vCard

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Amara D, Wolf DM, van 't Veer L, Esserman L, Campbell M, Yau C. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer. Breast Cancer Res Treat. 2016 Nov 4. PMID: 27815749.
        View in: PubMed
      2. Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2016 Oct 26. PMID: 27785654.
        View in: PubMed
      3. Cox C, Chen Y, Cress R, Semrad AM, Semrad T, Gosnell JE, Campbell MJ. Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry. Gland Surg. 2016 Aug; 5(4):398-404. PMID: 27563561.
        View in: PubMed
      4. Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. Thyroid. 2016 Mar; 26(3):373-80. PMID: 26914539.
        View in: PubMed
      5. Campbell MJ, Seib CD, Candell L, Gosnell JE, Duh QY, Clark OH, Shen WT. The underestimated risk of cancer in patients with multinodular goiters after a benign fine needle aspiration. World J Surg. 2015 Mar; 39(3):695-700. PMID: 25446471.
        View in: PubMed
      6. Campbell MJ, Sicuro P, Alseidi A, Blackmore CC, Ryan JA. Two-phase (low-dose) computed tomography is as effective as 4D-CT for identifying enlarged parathyroid glands. Int J Surg. 2015 Feb; 14:80-4. PMID: 25597235.
        View in: PubMed
      7. Campbell MJ, Candell L, Seib CD, Gosnell JE, Duh QY, Clark OH, Shen WT. Unanticipated thyroid cancer in patients with substernal goiters: are we underestimating the risk? Ann Surg Oncol. 2015 Apr; 22(4):1214-8. PMID: 25316492.
        View in: PubMed
      8. Crane CA, Austgen K, Haberthur K, Hofmann C, Moyes KW, Avanesyan L, Fong L, Campbell MJ, Cooper S, Oakes SA, Parsa AT, Lanier LL. Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. Proc Natl Acad Sci U S A. 2014 Sep 2; 111(35):12823-8. PMID: 25136121; PMCID: PMC4156766.
      9. Seib CD, Greenblatt DY, Campbell MJ, Shen WT, Gosnell JE, Clark OH, Duh QY. Adrenalectomy outcomes are superior with the participation of residents and fellows. J Am Coll Surg. 2014 Jul; 219(1):53-60. PMID: 24702888; PMCID: PMC4065814.
      10. Swift AJ, Rajaram S, Campbell MJ, Hurdman J, Thomas S, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG. Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2014 Jan; 7(1):100-6. PMID: 24275955.
        View in: PubMed
      11. Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PLoS One. 2013; 8(10):e79114. PMID: 24205370; PMCID: PMC3812150.
      12. Fotheringham J, Jacques RM, Fogarty D, Tomson CR, El Nahas M, Campbell MJ. Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data. Nephrol Dial Transplant. 2014 Feb; 29(2):422-30. PMID: 24052459.
        View in: PubMed
      13. Adisa CA, Eleweke N, Alfred AA, Campbell MJ, Sharma R, Nseyo O, Tandon V, Mukhtar R, Greninger A, Risi JD, Esserman LJ. Biology of breast cancer in Nigerian women: a pilot study. Ann Afr Med. 2012 Jul-Sep; 11(3):169-75. PMID: 22684136.
        View in: PubMed
      14. Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Esserman LJ. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer. Ann Surg Oncol. 2012 Nov; 19(12):3979-86. PMID: 22622474.
        View in: PubMed
      15. Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ. Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat. 2011 Nov; 130(2):635-44. PMID: 21717106.
        View in: PubMed
      16. Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ. Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn. 2011 Jan; 11(1):91-100. PMID: 21171924.
        View in: PubMed
      17. Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, Olopade OI, Esserman LJ. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat. 2011 Aug; 128(3):703-11. PMID: 20842526.
        View in: PubMed
      18. Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(1):137-44. PMID: 19728082; PMCID: PMC4087110.
      19. Ryan CJ, Zavodovskaya M, Youngren JF, Campbell M, Diamond M, Jones J, Shiry L, Allan G, Maddux BA, Goldfine ID. Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells. Prostate. 2008 Aug 1; 68(11):1232-40. PMID: 18491370.
        View in: PubMed
      20. Zavodovskaya M, Campbell MJ, Maddux BA, Shiry L, Allan G, Hodges L, Kushner P, Kerner JA, Youngren JF, Goldfine ID. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. J Cell Biochem. 2008 Feb 1; 103(2):624-35. PMID: 17562544.
        View in: PubMed
      21. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. Breast cancer growth prevention by statins. Cancer Res. 2006 Sep 1; 66(17):8707-14. PMID: 16951186.
        View in: PubMed
      22. Jabrane-Ferrat N, Campbell MJ, Esserman LJ, Peterlin BM. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice. Cancer Gene Ther. 2006 Nov; 13(11):1002-10. PMID: 16841083.
        View in: PubMed
      23. Kennedy CR, McCann DC, Campbell MJ, Law CM, Mullee M, Petrou S, Watkin P, Worsfold S, Yuen HM, Stevenson J. Language ability after early detection of permanent childhood hearing impairment. N Engl J Med. 2006 May 18; 354(20):2131-41. PMID: 16707750.
        View in: PubMed
      24. Kumar AS, Campbell M, Benz CC, Esserman LJ. A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. J Clin Oncol. 2006 May 1; 24(13):2127; author reply 2127-8. PMID: 16648516.
        View in: PubMed
      25. Gable KL, Maddux BA, Penaranda C, Zavodovskaya M, Campbell MJ, Lobo M, Robinson L, Schow S, Kerner JA, Goldfine ID, Youngren JF. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol Cancer Ther. 2006 Apr; 5(4):1079-86. PMID: 16648580.
        View in: PubMed
      26. Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Res Treat. 2005 Nov; 94(1):37-46. PMID: 16142439.
        View in: PubMed
      27. Maheswaran R, Haining RP, Brindley P, Law J, Pearson T, Fryers PR, Wise S, Campbell MJ. Outdoor air pollution, mortality, and hospital admissions from coronary heart disease in Sheffield, UK: a small-area level ecological study. Eur Heart J. 2005 Dec; 26(23):2543-9. PMID: 16166102.
        View in: PubMed
      28. Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res. 2005 Jul; 19(7):649-51. PMID: 16161030.
        View in: PubMed
      29. Campbell MJ, Scott J, Maecker HT, Park JW, Esserman LJ. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat. 2005 May; 91(2):163-71. PMID: 15868444.
        View in: PubMed
      30. Maheswaran R, Haining RP, Brindley P, Law J, Pearson T, Fryers PR, Wise S, Campbell MJ. Outdoor air pollution and stroke in Sheffield, United Kingdom: a small-area level geographical study. Stroke. 2005 Feb; 36(2):239-43. PMID: 15604422.
        View in: PubMed
      31. Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C, Lee JD. Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells. Cancer Res. 2004 Nov 1; 64(21):7732-9. PMID: 15520177.
        View in: PubMed
      32. Shoemaker M, Cohen I, Campbell M. Reduction of MTT by aqueous herbal extracts in the absence of cells. J Ethnopharmacol. 2004 Aug; 93(2-3):381-4. PMID: 15234781.
        View in: PubMed
      33. Ulrich LS, Wells M, Sturdee DW, Barlow DH, O'Brien K, Campbell MJ, Vessey MP, Bragg AJ. [Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy. A follow up study]. Ugeskr Laeger. 2003 Sep 8; 165(37):3530-2. PMID: 14531356.
        View in: PubMed
      34. Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D. Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res. 2002 Nov-Dec; 22(6C):3843-52. PMID: 12553004.
        View in: PubMed
      35. Wells M, Sturdee DW, Barlow DH, Ulrich LG, O'Brien K, Campbell MJ, Vessey MP, Bragg AJ. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. BMJ. 2002 Aug 3; 325(7358):239. PMID: 12153918; PMCID: PMC117635.
      36. Campbell MJ, Wollish WS, Lobo M, Esserman LJ. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. In Vitro Cell Dev Biol Anim. 2002 Jun; 38(6):326-33. PMID: 12513120.
        View in: PubMed
      37. Mukherjee S, Louie SG, Campbell M, Esserman L, Shyamala G. Ductal growth is impeded in mammary glands of C-neu transgenic mice. Oncogene. 2000 Dec 7; 19(52):5982-7. PMID: 11146549.
        View in: PubMed
      38. Borden EC, Esserman L, Linder DJ, Campbell MJ, Fulton AM. Biological therapies for breast carcinoma: concepts for improvement in survival. Semin Oncol. 1999 Aug; 26(4 Suppl 12):28-40. PMID: 10482192.
        View in: PubMed
      39. Esserman LJ, Lopez T, Montes R, Bald LN, Fendly BM, Campbell MJ. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice. Cancer Immunol Immunother. 1999 Feb; 47(6):337-42. PMID: 10203064.
        View in: PubMed
      40. Hsu FJ, Kwak L, Campbell M, Liles T, Czerwinski D, Hart S, Syrengelas A, Miller R, Levy R. Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann N Y Acad Sci. 1993 Aug 12; 690:385-7. PMID: 8368764.
        View in: PubMed
      41. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med. 1992 Oct 22; 327(17):1209-15. PMID: 1406793.
        View in: PubMed
      42. Kwak LW, Campbell MJ, Levy R. Tumor resistance induced by syngeneic bone marrow transplantation and enhanced by interleukin 2: a model for the graft versus leukemia reaction. Cancer Res. 1992 Aug 1; 52(15):4117-20. PMID: 1638524.
        View in: PubMed
      43. Clayberger C, Luna-Fineman S, Lee JE, Pillai A, Campbell M, Levy R, Krensky AM. Interleukin 3 is a growth factor for human follicular B cell lymphoma. J Exp Med. 1992 Feb 1; 175(2):371-6. PMID: 1732410; PMCID: PMC2119105.
      44. Campbell MJ, Zelenetz AD, Levy S, Levy R. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992 Feb; 29(2):193-203. PMID: 1542297.
        View in: PubMed
      45. Kwak LW, Campbell MJ, Zelenetz AD, Levy R. Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy. Blood. 1991 Nov 15; 78(10):2768-72. PMID: 1824269.
        View in: PubMed
      46. Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphomas. Blood. 1991 Sep 15; 78(6):1561-8. PMID: 1909196.
        View in: PubMed
      47. Zelenetz AD, Campbell MJ, Bahler DW, Takahashi S, Oren R, Esserman L, Umetsu DT, Kwak LW, Maloney DG, Brown S. Follicular lymphoma: a model of lymphoid tumor progression in man. Ann Oncol. 1991 Feb; 2 Suppl 2:115-22. PMID: 2049308.
        View in: PubMed
      48. Kwak LW, Campbell M, Levy R. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model. Cancer Detect Prev. 1991; 15(4):323-5. PMID: 1794139.
        View in: PubMed
      49. Kwak LW, Campbell MJ, Zelenetz AD, Levy R. Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin. Blood. 1990 Dec 1; 76(11):2411-7. PMID: 2257310.
        View in: PubMed
      50. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol. 1990 Aug 1; 145(3):1029-36. PMID: 2373859.
        View in: PubMed
      51. Berinstein N, Campbell MJ, Lam K, Carswell C, Levy S, Levy R. Idiotypic variation in a human B lymphoma cell line. J Immunol. 1990 Jan 15; 144(2):752-8. PMID: 2295809.
        View in: PubMed
      52. Levy S, Campbell MJ, Levy R. Functional immunoglobulin light chain genes are replaced by ongoing rearrangements of germline V kappa genes to downstream J kappa segment in a murine B cell line. J Exp Med. 1989 Jul 1; 170(1):1-13. PMID: 2501443; PMCID: PMC2189373.
      53. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor. Int Rev Immunol. 1989; 4(4):251-70. PMID: 2519929.
        View in: PubMed
      54. Campbell MJ, Esserman L, Levy R. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide. J Immunol. 1988 Nov 1; 141(9):3227-33. PMID: 3049819.
        View in: PubMed
      55. Basham TY, Race ER, Campbell MJ, Reid TR, Levy R, Merigan TC. Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action. J Immunol. 1988 Oct 15; 141(8):2855-60. PMID: 2971732.
        View in: PubMed
      56. Starnes CO, Carroll WL, Campbell MJ, Houston LL, Apell G, Levy R. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants. J Immunol. 1988 Jul 1; 141(1):333-9. PMID: 3132505.
        View in: PubMed
      57. Campbell MJ, Carroll W, Kon S, Thielemans K, Rothbard JB, Levy S, Levy R. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J Immunol. 1987 Oct 15; 139(8):2825-33. PMID: 3498771.
        View in: PubMed
      58. Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. Blood. 1987 Jan; 69(1):199-210. PMID: 2431729.
        View in: PubMed
      59. Campbell M, Bieber M, Levy R, Teng NN. Influence of avidity and idiotope recognition on the modulation of surface immunoglobulin on malignant human B cells by rat monoclonal anti-idiotype antibodies. J Immunol. 1986 Apr 15; 136(8):2983-8. PMID: 3485677.
        View in: PubMed
      60. Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol. 1986 Feb 1; 136(3):1123-30. PMID: 3484499.
        View in: PubMed
      Michael's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP